Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Initial Groningen experiences with dynamic cardiomyoplasty]

M P van den Berg1, M H Brouwer, D S Wijnberg

  • 1Academisch Ziekenhuis, Thoraxcentrum, Groningen.

Nederlands Tijdschrift Voor Geneeskunde
|July 26, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Predictors for Progression of Scoliosis in Rett Syndrome.

Developmental neurorehabilitation·2024
Same author

Cardiac [<sup>99m</sup>Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?

European journal of nuclear medicine and molecular imaging·2023
Same author

Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy.

European heart journal. Cardiovascular Imaging·2022
Same author

Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST).

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

New developments in adult congenital heart disease.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2020
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Cardiomyoplasty offers heart failure symptom relief but carries a risk of sudden death from ventricular arrhythmias. Further research is needed to prevent fatal arrhythmias and improve patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Heart failure management remains a significant clinical challenge.
  • Medically refractory heart failure often requires advanced surgical interventions.

Observation:

  • Four patients with refractory heart failure underwent cardiomyoplasty.
  • The surgical procedure and post-operative training were uneventful.

Findings:

  • One patient showed no improvement in heart failure symptoms.
  • Three patients experienced significant symptom relief post-cardiomyoplasty.
  • All three patients who improved died suddenly within one year, likely due to ventricular arrhythmias.

Implications:

  • Cardiomyoplasty shows potential for heart failure treatment.

Related Experiment Videos

  • Preventing sudden cardiac death is crucial for the success of cardiomyoplasty.
  • Investigating implantable cardioverter-defibrillators may mitigate mortality risk.